Ro (Roman) AI Market Strategy Report - Hair Loss Treatments

Answer Capsule

Ro (Roman) holds the weakest AI recommendation position among the 10 tracked brands in the hair loss treatment category for June 2026, capturing just $45,638 in monthly AI Authority Value against a total category opportunity of $53.2 million. The brand appears in only 2.4% of all observations and converts to a valid recommendation in just 1.7% of cases. The clearest win is a net sentiment score of 0.94 in the consideration cluster, where positive framing is the strongest of any tracked brand. The clearest weakness is complete absence from the evaluation cluster and near-zero presence in the pricing cluster, the two moments where buyer decisions form. The clearest opportunity is converting that positive consideration-stage framing into recommendation coverage in comparison and decision contexts.

Who This Report Is For

This report is for Ro (Roman) marketing, growth, and brand strategy leaders who need to understand why the brand is largely invisible in AI-driven hair loss treatment discovery and what specific gaps competitors are exploiting at the recommendation stage.

Report Card

• Report type: AI Company Market Strategy Report
• Target company: Ro (Roman)
• Category / market studied: Hair Loss Treatments
• Reporting month: June 2026
• AI platforms tracked: ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity
• Public high-intent clusters: 3 (Best Telehealth and Online Prescription Services, Telehealth Platform Comparisons, Telehealth and Online Prescription Pricing)
• AI observations analyzed: 1,102
• Competitors tracked: 10 (Nutrafol, Rogaine, Keeps, Hims, Happy Head, Bosley, HairClub, Folexin, Propecia by Merck, Ro (Roman))

Executive Summary

Ro (Roman) holds the weakest AI recommendation position among the 10 tracked brands in the hair loss treatment category. The brand appears in only 26 out of 1,102 observations, with 19 positive mentions, 6 neutral mentions, and 1 negative mention. A valid recommendation coverage rate of 1.7% means AI systems rarely advance Ro (Roman) as a treatment option, even when the brand is present in a response.

The strongest cluster for Ro (Roman) is the consideration cluster, Best Telehealth and Online Prescription Services, where it achieves a monthly AI Authority Value of $45,287 and a valid recommendation coverage rate of 3.6%. This is the only cluster where the brand registers meaningful recommendation activity. The consideration cluster is also where Ro (Roman) posts its highest net sentiment score of 0.94, the strongest positive framing ratio among all tracked brands in that cluster.

The evaluation cluster, Telehealth Platform Comparisons, presents the sharpest contrast. Ro (Roman) appears in only 5 of 310 observations, with 4 neutral mentions, 1 negative mention, and zero positive mentions. The net sentiment score of -0.2 is the only negative score the brand registers across any cluster or platform. Consumers comparing telehealth platforms in AI responses are not seeing Ro (Roman) recommended.

The pricing cluster, Telehealth and Online Prescription Pricing, is the highest-intent buying moment in the dataset and the most commercially significant gap. Ro (Roman) appears in only 5 of 376 observations, carries an average recommended rank of 4.75 (the worst in the category), and contributes almost nothing to the brand's monthly AI Authority Value from this cluster. Nutrafol leads this cluster with a 26.9% top-10 rate and an average rank of 2.26. Ro (Roman) is being displaced by every major competitor at the decision moment.

On a platform basis, Google AI Mode is the only platform where Ro (Roman) achieves meaningful recommendation coverage, with a 6.5% positive visibility rate and $16,365 in monthly AI Authority Value. Gemini contributes $29,156 in authority value at a 2.7% positive visibility rate. On ChatGPT, Copilot, Google AI Overviews, and Perplexity, Ro (Roman) registers near-zero or zero presence. The brand has zero rank-one recommendations across all six platforms.

What Ro (Roman) Is Winning

Ro (Roman) has one narrow but meaningful recommendation pocket in the consideration cluster. When AI systems retrieve the brand in Best Telehealth and Online Prescription Services prompts, the framing is positive at a net score of 0.94, the highest positive framing ratio among all tracked brands in that cluster. This shows that the brand's core value proposition is understood and respected by AI systems when they do retrieve it.

On Google AI Mode, Ro (Roman) achieves a 6.5% positive visibility rate and a 4.5% top-10 rate, making this the only platform where the brand achieves consistent recommendation coverage. The concentration of positive signal on Google AI Mode suggests that the retrieval mechanisms on that platform are more aligned with Ro (Roman)'s current public evidence layer than other platforms are.

The brand's overall net sentiment score of 0.69 is higher than Nutrafol's score of 0.57 and comparable to Hims at 0.70. When Ro (Roman) appears, the framing is generally positive. The core problem is not negative framing. It is insufficient retrieval frequency and an inability to convert presence into recommendation credit, particularly outside the consideration cluster.

Where Ro (Roman) Has the Clearest AI Visibility Gaps

The evaluation cluster is the most acute gap. In Telehealth Platform Comparisons, Ro (Roman) appears in only 5 of 310 observations, posts zero positive mentions, and earns zero valid recommendations. The net sentiment score of -0.2 is the brand's only negative cluster score. Consumers who are actively comparing telehealth platforms in AI responses are not seeing Ro (Roman) advanced as an option, and in the rare cases where the brand appears, it is framed neutrally or negatively.

The pricing cluster gap is equally severe and more commercially significant. Ro (Roman) appears in only 5 of 376 observations in the highest-intent buying cluster. Its average recommended rank of 4.75 is the worst in the category, meaning that even when the brand receives a recommendation, it appears near the bottom of the returned list. Nutrafol and Rogaine dominate this cluster with strong top-10 rates and average ranks well inside the top three. Ro (Roman) is being displaced at the moment when purchase decisions are most likely to form.

Platform-level absence compounds both cluster gaps. ChatGPT has zero Ro (Roman) mentions across 175 observations. Copilot has 2 mentions with a net negative sentiment score of -0.50. Perplexity has 2 neutral mentions with zero recommendation value. Google AI Overviews has 1 neutral mention. These four platforms collectively represent a large portion of AI-driven discovery activity, and Ro (Roman) is effectively invisible across all of them.

The brand also holds zero rank-one recommendations across all six platforms. Rogaine holds 156 rank-one recommendations in the same dataset. Happy Head, a smaller brand by market presence, holds 48. Ro (Roman) is never the first brand an AI system recommends in any tracked prompt cluster or platform combination.

Biggest Opportunity

The clearest opportunity for Ro (Roman) is converting its established positive framing in the consideration cluster into recommendation coverage in the evaluation and pricing clusters. The brand's net sentiment score of 0.94 in consideration-stage prompts confirms that AI systems frame Ro (Roman) positively when they retrieve it. That framing foundation exists. What does not exist is the citation architecture required to justify recommendation credit in comparison and decision contexts.

Building retrievable content that positions Ro (Roman) as a directly comparable option alongside Nutrafol, Rogaine, and Keeps in telehealth platform comparison articles, treatment pricing guides, and clinical review content would address the source footprint gap directly. AI systems recommending competitors in evaluation and pricing prompts are doing so because those brands have denser, more comparison-friendly public evidence layers. Ro (Roman) has the positive framing required to earn recommendations. It needs the citation architecture to make those recommendations accessible at the evaluation and pricing stage.

Prompt Evidence

Google AI Mode / Consideration Prompt: "What are the best telehealth and online prescription services for hair loss?" Result: Ro (Roman) appeared with a 6.5% positive visibility rate, its strongest platform performance across all six tracked platforms.

Gemini / Consideration Prompt: "Best telehealth and online prescription services for hair loss" Result: Ro (Roman) achieved a 2.7% positive visibility rate and contributed $29,156 in monthly AI Authority Value, its second-strongest platform signal.

Copilot / Evaluation Prompt: "Compare telehealth platforms for hair loss treatment" Result: Ro (Roman) appeared in 2 of 310 observations with 1 neutral and 1 negative mention, zero valid recommendations, and a net sentiment score of -0.50.

Perplexity / Pricing Prompt: "Telehealth and online prescription pricing for hair loss" Result: Ro (Roman) registered 2 neutral mentions across 81 observations with zero recommendation value and an average recommended rank of 4.75.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map the specific prompts, platforms, and competitor responses where Ro (Roman) is retrieved but not recommended, identifying the exact gaps in citation architecture and source footprint that explain the evaluation and pricing cluster absence.

Phase 2: Recommendation Readiness Plan Identify the missing source types, including comparison pages, pricing guides, and clinical references, that AI systems require to justify recommending Ro (Roman) in evaluation and decision-stage clusters.

Phase 3: Owned Answer Layer Buildout Develop structured content that positions Ro (Roman) as a directly comparable option in telehealth platform comparison, pricing, and treatment evaluation contexts where the brand currently registers zero recommendation credit.

Phase 4: Citation and Authority Layer Development Build the external citation architecture, including editorial reviews, clinical references, and third-party comparison content, that AI systems use to validate and rank recommendations in high-intent clusters.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track Ro (Roman)'s recommendation coverage, rank position, cluster performance, and sentiment across all six platforms to measure progress against the June 2026 baseline and adjust strategy as AI retrieval patterns shift.

Why This Matters

Ro (Roman) is not being ignored by AI systems. It is being retrieved infrequently and, when retrieved, is rarely advanced as a recommended option. In the evaluation and pricing clusters, where consumers are actively comparing telehealth platforms and assessing treatment costs, Ro (Roman) is effectively absent. This is not a brand awareness problem. It is a recommendation architecture problem.

The brands capturing AI recommendation value in this category have strong citation architecture, comparison-friendly content, and retrievable clinical references that give AI systems the evidence needed to justify a recommendation. Ro (Roman) has positive framing when it appears. It does not appear often enough, and it does not appear in the clusters where buyer decisions form. The next move is to build the source footprint that converts occasional positive mentions into consistent recommendation coverage across the high-intent evaluation and pricing clusters.

Core Metrics

• Mentions: 26
• Valid recommendations: 19
• Top 3 recommendation count: 7
• Rank 1 recommendation count: 0
• Average recommended rank: 3.58
• Positive mentions: 19
• Neutral mentions: 6
• Negative mentions: 1
• Raw mention presence rate: 2.4%
• Valid recommendation coverage: 1.7%
• Top 3 recommendation rate: 0.6%
• Rank 1 recommendation rate: 0.0%
• Strongest cluster by recommendation behavior: Best Telehealth and Online Prescription Services (consideration)
• Strongest platform by recommendation behavior: Google AI Mode

Sentiment Score

Sentiment Score = (19 positive x 1 + 6 neutral x 0 + 1 negative x -1) / 26 total mentions = 0.69

When Ro (Roman) is mentioned by AI systems, the framing is predominantly positive. However, this score must be interpreted carefully. A sentiment score of 0.69 does not mean the brand is being recommended. It means the brand is framed positively in the small number of cases where it appears at all. The raw mention count of 26 out of 1,102 observations is the more important diagnostic signal. Ro (Roman) is not being retrieved often enough to generate meaningful recommendation value, and positive framing in isolated mentions does not compensate for absence in evaluation and pricing clusters.

Unclassified mention counts are misleading because they treat a neutral listing and a positive recommendation as equivalent contributions to brand visibility. Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention carry different commercial weight and must be classified separately before any interpretation of AI visibility can be trusted. Counting all mentions as wins produces a false picture of recommendation-stage performance.

Sentiment by Platform

Methodology

1. This report is a benchmark-based AI Company Market Strategy Report for Ro (Roman) in the Hair Loss Treatments category, powered by the LLM Authority Index dataset for June 2026.
2. The reporting window is June 2026. Data was collected and aggregated on June 16, 2026.
3. Six AI platforms were tracked: ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, and Perplexity.
4. A total of 1,102 observations were analyzed across three public high-intent prompt clusters included in this version of the report.
5. The competitor universe includes 10 brands: Nutrafol, Rogaine, Keeps, Hims, Happy Head, Bosley, HairClub, Folexin, Propecia (Merck), and Ro (Roman).
6. Three public clusters are reported: Best Telehealth and Online Prescription Services (consideration stage, buyer stage multiplier 1.0), Telehealth Platform Comparisons (evaluation stage, buyer stage multiplier 1.25), and Telehealth and Online Prescription Pricing (decision stage, buyer stage multiplier 1.5). The full LLM Authority Index report includes 10 clusters.
7. Stage 0 refers to the raw extraction of AI responses before classification and scoring. All metrics in this report are based on classified and scored observations.
8. A mention is recorded when a company appears in an AI-generated response, regardless of sentiment, rank, or recommendation status.
9. A valid recommendation is a positive, shortlist-quality recommendation or ranked recommendation that earns recommendation credit in the scoring model. Visibility and recommendation credit are not the same metric and are not interchangeable.
10. Monthly AI Authority Value is a modeled benchmark estimate. It is not revenue, pipeline, or booked demand. It represents the relative recommendation value weight assigned to a brand's AI-generated recommendation activity within the category and reporting period.
11. Ro (Roman)'s total mention count of 26 observations means that individual platform and cluster metrics should be read as directional indicators rather than statistically robust findings. Platform-level scores derived from fewer than 5 mentions carry wider uncertainty.
12. This report covers 3 of 10 tracked clusters from the LLM Authority Index June 2026 dataset. Category-level totals, competitor rankings, and full cluster coverage are available in the full benchmark report.

See How AI Is Recommending Your Brand

The public benchmark shows the market shape and where Ro (Roman) stands relative to 10 tracked competitors across six AI platforms. A company-specific analysis maps which prompts the brand wins or loses, which AI platforms are under-recognizing the brand, which source layers are shaping current recommendations, and what changes in the owned and citation evidence layer may improve AI shortlist eligibility. Contact CiteWorks Studio for an AI Visibility Audit that maps your brand's recommendation-stage visibility and identifies the specific gaps competitors are currently exploiting.